Management of patients with pre-therapeutic advanced liver fibrosis following HCV eradication

Patients with HCV-related bridging fibrosis or cirrhosis remain at risk of developing life-threatening complications even after achieving a sustained virological response. Although it is reduced, the risk of liver-related events in these patients justifies their inclusion in surveillance programmes...

Descripción completa

Detalles Bibliográficos
Autores principales: Nahon, Pierre, Ganne-Carrié, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005771/
https://www.ncbi.nlm.nih.gov/pubmed/32039400
http://dx.doi.org/10.1016/j.jhepr.2019.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005771/
https://www.ncbi.nlm.nih.gov/pubmed/32039400
http://dx.doi.org/10.1016/j.jhepr.2019.11.001

Ejemplares similares